4-甲氧基-2-硝基苯甲醛 | 22996-21-0

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 烃类硝化物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲氧基-2-硝基苯甲醛
• 中文别名: 2-硝基-4-甲氧基苯甲醛；4-甲氧基-2-硝基-苯甲醛
• 英文名称: 4-methoxy-2-nitro-benzaldehyde
• 英文别名: 2-nitro-4-methoxybenzaldehyde；4-Methoxy-2-nitrobenzaldehyde
• CAS: 22996-21-0
• 化学式: C₈H₇NO₄
• mdl: MFCD00024254
• 分子量: 181.148
• InChiKey: KLTDQLIGNSBZPO-UHFFFAOYSA-N

物化性质

• 熔点：
  95.5-96 °C(Solv: chloroform (67-66-3); ligroine (8032-32-4))
• 沸点：
  354.7±27.0 °C(Predicted)
• 密度：
  1.322±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  72.1
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2913000090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  4-甲氧基-2-硝基苯甲醛 在 sodium tetrahydroborate 、 三溴化磷 作用下， 以 甲醇 、 甲苯 为溶剂， 反应 1.5h， 生成 4-甲氧基-2-硝基溴苄
  参考文献：
  名称：

  Discovery of a Clinical Stage Multi-Kinase Inhibitor Sodium (E)-2-{2-Methoxy-5-[(2′,4′,6′-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): Synthesis, Structure–Activity Relationship, and Biological Activity

  摘要：

  Cyclin D proteins are elevated in many cancer cells, and targeted deletion of cyclin D1 gene in the mammary tissues protects mice from breast cancer, Accordingly, there is an increasing awareness of this novel nonenzymatic target for cancer therapeutics. We have developed novel, nonalkylating styrylbenzylsulfones that induce cell death in wide variety of cancer cells without affecting the proliferation and survival of normal cells. The development of derivatized styrylbenzylsulfones followed logically from a tumor cell cytotoxicity screen performed in our laboratory that did not have an a priori target profile. Modifications of some of the precursor molecules led to lead optimization with regard to tumor cell cytotoxicity. In this report we describe the synthesis and structure-activity relationships of novel, nonalkylating (E)-styrylbenzylsulfones and the development of the novel anticancer agent sodium (E)-2-{2-methoxy-5-[(2',4',6'-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na), which is in phase III trials for myelodysplastic syndromes (MDS) associated with aberrant expression of cyclin D proteins.

  DOI：

  10.1021/jm200570p
• 作为产物：
  描述：

  4-甲氧基-2-硝基溴苄 在 tetra(n-butyl)ammonium dichromate(VI) 作用下， 以 氯仿 为溶剂， 反应 8.0h， 以75%的产率得到4-甲氧基-2-硝基苯甲醛
  参考文献：
  名称：

  笼状辣椒素的模型化合物：设计，合成和光反应性。

  摘要：

  制备具有通过醚或碳酸酯键与N-（4-羟基-3-甲氧基苄基）乙酰胺（2）共价键合的取代硝基苄基的分子。这些化合物在363nm的辐射下分解。具有碳酸酯键的那些分解速率比具有醚键的那些分解速率慢。由于苄基碳的电子特性，具有二甲氧基取代的苄基的分子比单甲氧基取代的苄基分解得更慢。

  DOI：

  10.1021/jo034616t

文献信息

• [EN] 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES<br/>[FR] 2 -ARYLAMINOQUINAZOLINES DESTINÉES AU TRAITEMENT DES MALADIES PROLIFÉRATIVES
  申请人：NOVARTIS AG

  公开号：WO2009153313A1

  公开（公告）日：2009-12-23

  The invention provides novel compounds that are inhibitors of PDKI. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or composition.

  这项发明提供了一种抑制PDKI的新型化合物。还提供了包括这些化合物的药物组合物，以及使用这些化合物或组合物治疗增殖性疾病，如癌症的方法。
• Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives
  作者：Michele Tonelli、Matteo Simone、Bruno Tasso、Federica Novelli、Vito Boido、Fabio Sparatore、Giuseppe Paglietti、Sabrina Pricl、Gabriele Giliberti、Sylvain Blois、Cristina Ibba、Giuseppina Sanna、Roberta Loddo、Paolo La Colla

  DOI：10.1016/j.bmc.2010.02.037

  日期：2010.4

  Seventy-six 2-phenylbenzimidazole derivatives were synthesized and evaluated in cell-based assays for cytotoxicity and antiviral activity against a panel of 10 RNA and DNA viruses. The most commonly affected viruses were, in decreasing order, CVB-2, BVDV, Sb-1, HSV-1, and YFV, while HIV-1 and VSV were not affected, and RSV, VV and Reo-1 were only susceptible to a few compounds. Thirty-nine compounds

  合成了76种2-苯基苯并咪唑衍生物，并在基于细胞的测定中评估了其对一组10种RNA和DNA病毒的细胞毒性和抗病毒活性。受影响最严重的病毒以降序排列，分别是CVB-2，BVDV，Sb-1，HSV-1和YFV，而HIV-1和VSV不受影响，RSV，VV和Reo-1仅易感一些化合物。39种化合物表现出 对至少一种病毒的高活性（EC 50 = 0.1–10μM），其中四种对VV（24，EC 50  = 0.1μM）和BVDV（50，具有EC 50的51和53 分别为1.5、0.8和1.0μM）。最后的化合物在低微摩尔浓度下抑制BVDV和HCV的NS5B RdRp，后者与前者具有结构相似性。所考虑的化合物代表了针对痘病毒，瘟病毒甚至HCV（它们是重要的人类和兽医病原体）的抗病毒剂开发的诱人线索。
• Cu(II)/Ag(I)-Catalyzed Cascade Reaction of Sulfonylhydrazone with Anthranils: Synthesis of 2-Aryl-3-sulfonyl Substituted Quinoline Derivatives
  作者：Fei Wang、Pei Xu、Shun-Yi Wang、Shun-Jun Ji

  DOI：10.1021/acs.orglett.8b00525

  日期：2018.4.20

  In this paper, a Cu(II)/Ag(I)-catalyzed cascade reaction of anthranils with sulfonylhydrazone to construct 2-phenyl-3-sulfonyl disubstituted quinoline derivatives under mild conditions was studied. The mechanism study indicated that this reaction involves radical addition, and new C–C, C–N, and C–S bonds were constructed in one step.

  本文研究了Cu（II）/ Ag（I）催化蒽与磺酰hydr的级联反应，在温和条件下构建2-苯基-3-磺酰基双取代喹啉衍生物。机理研究表明，该反应涉及自由基加成，一步就可以构建新的C–C，C–N和C–S键。
• [EN] ARYLOXYACETYLINDOLES AND ANALOGS AS ANTIBIOTIC TOLERANCE INHIBITORS<br/>[FR] ARYLOXYACÉTYLINDOLES ET ANALOGUES EN TANT QU'INHIBITEURS DE TOLÉRANCE AUX ANTIBIOTIQUES
  申请人：SPERO THERAPEUTICS INC

  公开号：WO2016112088A1

  公开（公告）日：2016-07-14

  The disclosure provides compounds and pharmaceutical compositions of aryloxyacetylindoles compounds and analogs useful for treating chronic and acute bacterial infections. Certain of the compounds are compounds of general Formula (I) (I) or a pharmaceutically acceptable salt or prodrug thereof. Certain compounds of this disclosure are MvfR inhibitors. MvfR inhibitors reduce the formation of antibiotic tolerant bacterial strains and are useful for treating Gram-negative bacterial infections and reducing the virulence of Pseudomonas aeruginosa. Methods of treating bacterial infections in a subject, including Pseudomonas aeruginosa infections, are also provided by the disclosure.

  该披露提供了芳基氧乙酰基吲哚化合物及类似物的化合物和药物组合物，用于治疗慢性和急性细菌感染。其中某些化合物是一般式(I)（I）的化合物或其药用可接受的盐或前药。该披露的某些化合物是MvfR抑制剂。MvfR抑制剂减少抗生素耐药细菌菌株的形成，对治疗革兰氏阴性细菌感染和减少铜绿假单胞菌的毒力有用。该披露还提供了治疗受试者细菌感染的方法，包括铜绿假单胞菌感染。
• Identification of Inhibitors of Cholesterol Transport Proteins Through the Synthesis of a Diverse, Sterol‐Inspired Compound Collection
  作者：Thomas Whitmarsh‐Everiss、Asger Hegelund Olsen、Luca Laraia

  DOI：10.1002/anie.202111639

  日期：2021.12.13

  A general strategy for the identification of selective cholesterol transport protein inhibitors through the synthesis of a diverse sterol-inspired compound collection is presented. Fusion of a primary sterol scaffold to diverse secondary natural product-derived scaffolds afforded hits against all of the Aster family of cholesterol transport proteins and selective inhibitors of Aster-C.

  介绍了通过合成多种甾醇化合物集合来鉴定选择性胆固醇转运蛋白抑制剂的一般策略。初级甾醇支架与多种次级天然产物衍生支架的融合提供了针对胆固醇转运蛋白的所有 Aster 家族和 Aster-C 的选择性抑制剂的攻击。